Very late recurrence of childhood acute lymphoblastic leukemia treated with chemoimmunotherapy: a report of three cases occurring 19, 11, and 9 years after discontinuation of chemotherapy

Salloum, Emile; Pico, José Luis; Herait, Patrice; Bayle, Chantal; Ghosn, Marwane; Moran, Angel; Friedman, Samuel; Hayat, Marcel.
Med. Ped. Oncol ; 17: 155-58, 1989. tab
Artículo en Inglés | URUCAN | ID: bcc-584

Documentos relacionados

  1. Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel.
  2. The Philadelphia Chromosome, from Negative to Positive: A Case Report of Relapsed Acute Lymphoblastic Leukemia Following Allogeneic Stem Cell Transplantation.
  3. Management of ALL in adults: 2024 ELN recommendations from a European expert panel.
  4. Single-cell analysis of acute lymphoblastic and lineage-ambiguous leukemia: approaches and molecular insights.
  5. Genetic Profiling in Children With Acute Lymphoblastic Leukemia Referred for Allogeneic Hematopoietic Stem Cell Transplantation.
  6. Post-PICU Cognitive and Psychological Outcomes in Children Receiving Treatments for Acute Lymphoblastic Leukemia.
  7. [Recent research on chimeric antigen receptor T cells in children with refractory/relapsed acute lymphoblastic leukemia].
  8. Prognosis of patients with acute lymphoblastic leukaemia relapsing after allogeneic stem cell transplantation.
  9. Mixed Phenotype/Lineage Leukemia: Has Anything Changed for 2021 on Diagnosis, Classification, and Treatment?
  10. Adverse events and efficacy of second-round CAR-T cell therapy in relapsed pediatric B-ALL.